Abstract
ASCO summarizes issues and recommendations related to the 340B Drug Pricing Program for policymakers to consider from the perspective of professionals dedicated to the prevention, diagnosis, and treatment of cancer.
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology(nursing),Oncology
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献